91 results match your criteria: "The Toledo Hospital[Affiliation]"

Thirty-day readmission rates, reasons, and costs for gastrointestinal angiodysplasia-related bleeding in the USA.

Eur J Gastroenterol Hepatol

January 2022

Division of Gastroenterology and Hepatology, Department of Medicine, West Virginia University, Morgantown, West Virginia, USA.

Background: Patients with gastrointestinal angiodysplasia (GIA)-related bleeding are at high risk for readmissions, resulting in significant morbidity and an economic burden on the healthcare system.

Aim: The aim of the study was to determine the 30-day readmission rate with reasons, predictors, and costs associated with GIA-related bleeding in the USA.

Methods: We queried the National Readmission Database to identify patients hospitalized with GIA-related bleeding in the year 2016 using the International Classification of Diseases, Tenth Revision (ICD-10) codes.

View Article and Find Full Text PDF

Objectives: We performed a prospective, single-arm clinical trial approved under a Food and Drug Administration Investigational Device Exemption to assess safety and efficacy of Perceval, a sutureless bovine pericardial aortic valve representing the initial US experience.

Methods: From June 2013 to January 2015, 300 patients (mean age 76.7 ± 7.

View Article and Find Full Text PDF

RNAseq analysis of bronchial epithelial cells to identify COPD-associated genes and SNPs.

BMC Pulm Med

March 2018

Division of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Toledo College of Medicine, 3000 Arlington Avenue, Toledo, OH, 43614, USA.

Background: There is a need for more powerful methods to identify low-effect SNPs that contribute to hereditary COPD pathogenesis. We hypothesized that SNPs contributing to COPD risk through cis-regulatory effects are enriched in genes comprised by bronchial epithelial cell (BEC) expression patterns associated with COPD.

Methods: To test this hypothesis, normal BEC specimens were obtained by bronchoscopy from 60 subjects: 30 subjects with COPD defined by spirometry (FEV1/FVC < 0.

View Article and Find Full Text PDF

Placental Alpha Microglobulin-1 Compared With Fetal Fibronectin to Predict Preterm Delivery in Symptomatic Women.

Obstet Gynecol

December 2017

University of California Irvine, Orange, California; St. David's Medical Center, Austin, Texas; Summa Health, Akron, Ohio; HonorHealth Scottsdale Shea Medical Center, Scottsdale, Arizona; the University of Kansas, Kansas City, Kansas; Meritus Health, Hagerstown, Maryland; South Shore Hospital, South Weymouth, Massachusetts; Promedica-The Toledo Hospital, Toledo, Ohio; St. Luke's Hospital of Kansas City, Kansas City, Missouri; the University at Buffalo-Women and Children's Hospital of Buffalo, Buffalo, New York; Stony Brook University School of Medicine, Stony Brook, New York; the University of California, Los Angeles, Los Angeles, California; the University of California San Diego, San Diego, California; the University of California, Davis, Sacramento, California; and the University of California, San Francisco, California.

Objective: To compare the rapid bedside test for placental α microglobulin-1 with the instrumented fetal fibronectin test for prediction of imminent spontaneous preterm delivery among women with symptoms of preterm labor.

Methods: We conducted a prospective observational study on pregnant women with signs or symptoms suggestive of preterm labor between 24 and 35 weeks of gestation with intact membranes and cervical dilatation less than 3 cm. Participants were prospectively enrolled at 15 U.

View Article and Find Full Text PDF

Gender and racial differences in surgical outcomes among adult patients with acute heart failure.

Heart Lung

December 2017

Department of Anesthesiology University of Michigan and Department of Anesthesiology Promedica, The Toledo Hospital, 4172 Cardiovascular Center, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-5861, USA.

Background: Approximately three million U.S. adult women have heart failure (HF), increasing their risk of adverse perioperative outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • Cilostazol demonstrates effectiveness in improving the maturation rates and longevity of arteriovenous access in hemodialysis patients compared to a control group not receiving the drug.
  • Patients treated with cilostazol were 3.8 times more likely to experience successful fistula maturation and had a significantly lower rate of complications and longer time until the first complication.
  • Although the time to maturation was similar for both groups, the cilostazol group had a significantly longer duration of functional access post-maturation, indicating potential benefits of cilostazol therapy in improving vascular access outcomes.
View Article and Find Full Text PDF

Background: The UNTOUCHED study will assess the safety and efficacy of the subcutaneous implantable cardioverter defibrillator (S-ICD) in the most common cohort of patients receiving ICDs. The primary goal is to evaluate the inappropriate shock (IAS)-free rate in primary prevention patients with a reduced ejection fraction (EF) and compare with a historical control of transvenous ICD patients with similar programming.

Methods And Results: The UNTOUCHED study is a global, multicenter, prospective, nonrandomized study of patients undergoing de novo S-ICD implantation for primary prevention of sudden cardiac death with a left ventricular EF ≤35%.

View Article and Find Full Text PDF

Minimally Invasive Mitral Valve Surgery II: Surgical Technique and Postoperative Management.

Innovations (Phila)

May 2017

From the *Northeast Georgia Physicians Group, Gainesville, GA USA; †Northwestern University, Feinberg School of Medicine, Chicago, IL USA; ‡Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, MN USA; §East Bay Cardiac Surgery Center, Oakland, CA USA; ∥Penn Presbyterian Medical Center, Philadelphia, PA USA; ¶The Toledo Hospital, Toledo, OH USA; #The Heart Hospital Baylor Plano, Plano, TX USA; **University of Virginia, Charlottesville, VA USA; ††Saint Elizabeth's Medical Center, Brighton, MA USA; ‡‡Gulf Coast Cardiothoracic & Vascular Surgeons, Ft. Myers, FL USA; §§Holy Spirit Northside Hospital, Chermside, Australia; ∥∥New York University School of Medicine, New York, NY USA; ¶¶Temple University, Philadelphia, PA USA; ##Swedish Heart and Vascular Institute, Seattle, WA USA; ***Penrose St. Francis Hospital, Colorado Springs, CO USA; †††Emory St. Joseph's Hospital, Atlanta, GA USA; ‡‡‡St. Thomas Hospital, Nashville, TN USA; §§§Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY USA; ∥∥∥South Florida Heart & Lung Institute, Doral, FL USA; ¶¶¶David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA USA; ###TriHealth Heart Institute, Cincinnati, OH USA; ****Central Maine Heart and Vascular Institute, Lewiston, ME USA; ††††Department of Cardiothoracic Surgery, Princeton Baptist Hospital, Birmingham, AL USA; and ‡‡‡‡Lankenau Medical Center, Wynnewood, PA USA.

Techniques for minimally invasive mitral valve repair and replacement continue to evolve. This expert opinion, the second of a 3-part series, outlines current best practices for nonrobotic, minimally invasive mitral valve procedures, and for postoperative care after minimally invasive mitral valve surgery.

View Article and Find Full Text PDF

Patients with advanced post-thrombotic syndrome (PTS) and chronic iliac vein obstruction suffer major physical limitations and impairment of health-related quality of life. Currently there is a lack of evidence-based treatment options for these patients. Early studies suggest that imaging-guided, catheter-based endovascular therapy can eliminate iliac vein obstruction and saphenous venous valvular reflux, resulting in reduced PTS severity; however, these observations have not been rigorously validated.

View Article and Find Full Text PDF

Background: The Lung Cancer Risk Test (LCRT) trial is a prospective cohort study comparing lung cancer incidence among persons with a positive or negative value for the LCRT, a 15 gene test measured in normal bronchial epithelial cells (NBEC). The purpose of this article is to describe the study design, primary endpoint, and safety; baseline characteristics of enrolled individuals; and establishment of a bio-specimen repository.

Methods/design: Eligible participants were aged 50-90 years, current or former smokers with 20 pack-years or more cigarette smoking history, free of lung cancer, and willing to undergo bronchoscopic brush biopsy for NBEC sample collection.

View Article and Find Full Text PDF

Invasive management of postthrombotic syndrome encompasses the two ends of the deep vein thrombosis spectrum, patients with acute iliofemoral deep vein thrombosis and those with chronic postthrombotic iliofemoral venous obstruction. Of all patients with acute deep vein thrombosis, those with involvement of the iliofemoral segments have the most severe chronic postthrombotic morbidity. Catheter-based techniques now permit percutaneous treatment to eliminate thrombus, restore patency, potentially maintain valvular function, and improve quality of life.

View Article and Find Full Text PDF

Background: Since the first aortic valve replacement through a right thoracotomy was reported in 1993, upper hemisternotomy and right anterior thoracotomy have become the predominant approaches for minimally invasive aortic valve replacement. Clinical studies have documented equivalent operative mortality, less bleeding, and reduced intensive care/hospital stay compared with conventional sternotomy despite longer procedure times. However, comparative trials face challenges due to patient preference, surgeon bias, and the lack of a standardized minimally invasive surgical approach.

View Article and Find Full Text PDF

Objective: When uterotonics fail to cause sustained uterine contractions and satisfactory control of hemorrhage after delivery, tamponade of the uterus can be effective in decreasing hemorrhage secondary to uterine atony.

Study Design: These data are from a postmarketing surveillance study of a novel dual-balloon catheter tamponade device, the Belfort-Dildy Obstetrical Tamponade System (ebb).

Results: A total of 57 women were enrolled: 55 women had the diagnosis of postpartum hemorrhage, and 51 women had uterine balloon placement within the uterine cavity.

View Article and Find Full Text PDF

Background: Extensive deep venous thrombosis (DVT) during pregnancy is usually treated with anticoagulation alone, risking significant post-thrombotic syndrome (PTS) in young patients. Catheter-directed thrombolysis (CDT) and operative venous thrombectomy have been safely and effectively used in nonpregnant patients, demonstrating significant reduction in post-thrombotic morbidity. This report reviews short- and long-term outcomes of 13 patients with extensive DVT of pregnancy treated with a strategy of thrombus removal.

View Article and Find Full Text PDF

Use of guideliner catheter for anomalous right coronary artery angiography and intervention.

J Invasive Cardiol

January 2013

Northwest Ohio Cardiology Consultants, ProMedica Heart and Vascular Institute, The Toledo Hospital, ProMedica Health System, 2940 N. McCord Road, Toledo, OH 43615 USA.

We report a case of the use of the GuideLiner catheter during transfemoral diagnostic angiography and intervention of an anomalous right coronary artery (RCA) after unsuccessful attempts to cannulate the RCA with other catheters. The GuideLiner catheter was successfully employed to coaxially engage the ostium of the RCA. Thrombotic disease appeared to be responsible for non-ST elevation myocardial infarction.

View Article and Find Full Text PDF

Nursing grand rounds is a way for staff nurses to present an interesting case through evidence-based practice. Idiopathic pulmonary arterial hypertension is an incurable syndrome that can devastate a patient. This article describes a patient's experience with idiopathic pulmonary arterial hypertension and outlines the pathophysiology, treatment, psychosocial issues, and nursing implications that were presented in a nursing grand rounds presentation at a hospital.

View Article and Find Full Text PDF

The standard of care for the treatment of acute deep venous thrombosis (DVT) is anticoagulation, which often prevents the formation of new thrombus and reduces the risk of pulmonary embolism (PE) but fails to eliminate the clot burden. Patients who have thrombus remaining in their deep venous system despite therapeutic anticoagulation are at high risk for developing symptoms of the postthrombotic syndrome, a debilitating condition that adversely affects their quality of life. Strategies of thrombus removal for acute DVT, such as operative thrombectomy, catheter-directed thrombolysis, and pharmacomechanical techniques, are designed to avoid postthrombotic morbidity by restoring patency to the deep veins, but there is concern that these techniques may result in fragmentation of clot and pulmonary embolization.

View Article and Find Full Text PDF